Cobra Biologics Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile by GlobalData

VIEWS: 0 PAGES: 18

Cobra Biologics Ltd. (Cobra Biologics) is a contract manufacturing organization (CMO). It is a leading cGMP CMO of biologics. It undertakes the development and manufacture of pharmaceuticals, recombinant proteins, monoclonal antibodies, DNA, viruses and cell line derived products for clinical trials and commercial supply. It provides an array of integrated and stand-alone development services, ranging from cell line development to the supply of investigational therapeutic product and market supply. The company operates through three GMP approved facilities located in Matfors, Sweden; Sodertalje, Sweden; and Keele, the UK. Cobra Biologics is headquartered in Keele, the UK.

More Info
									          Cobra Biologics Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances
                                          Profile
       Reference Code: GDPH213854D                                                                                                             Publication Date: APR 2013

      Company Overview                                                                                        Key Facts
      Cobra Biologics Ltd. (Cobra Biologics) is a contract manufacturing organization
                                                                                                              Cobra Biologics Ltd., Pharmaceuticals &
      (CMO). It is a leading cGMP CMO of biologics. It undertakes the development and
                                                                                                              Healthcare, Key Facts
      manufacture of pharmaceuticals, recombinant proteins, monoclonal antibodies,
      DNA, viruses and cell line derived products for clinical trials and commercial supply.                   Web Address                           www.cobrabio.com
      It provides an array of integrated and stand-alone development services, ranging
                                                                                                               Revenue (US$ million)                                NA
      from cell line development to the supply of investigational therapeutic product and
      market supply. The company operates through three GMP approved facilities                                Number of Employees                                  NA
      located in Matfors, Sweden; Sodertalje, Sweden; and Keele, the UK. Cobra                                 GlobalData
      Biologics is headquartered in Keele, the UK.

      Financial Deals Landscape
        Cobra Biologics Ltd., Pharmaceuticals & Healthcare, Deals by                      Cobra Biologics Ltd., Pharmaceuticals & Healthcare, Deals
        Type, 2007 to YTD 2013                                                            By Year, 2007 to YTD 2013


                                                                                                                                                     2    2
                                                                                                          2

                                                                                           No. of Deals
                                                                                                          1


                                                                                                                 0         0      0        0                         0
                                                                                                          0
                                                                                                               2007       2008   2009     2010   2011    2012       YTD
                                                                                                                                                                    2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Cobra Biologics Ltd., Pharmaceuticals & Healthcare, Deals                        Cobra Biologics Ltd., Pharmaceuticals & Healthcare, Deals
         By Region, 2007 to YTD 2013                                                      By Therapy Area, 2007 to YTD 2013

                         5
                               4                                                                                      1               1
          No. of Deals




                         4                                                                                1
                                                                                           No. of Deals




                         3
                         2
                                          1
                         1
                                                      0            0
                         0
                             Europe    Middle       Asia-       South                                                                            0              0
                                      East and     Pacific       and                                      0
                                       Africa                  Central                                           Infectiou Oncology Cardiova             Central
                                                               America                                           s Disease           scular              Nervous
                                                                                                                                                         System


         Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    Note: Deals include all announced pharmaceuticals & healthcare deals
                                                                                          from 2006 onwards, GlobalData




Cobra Biologics Ltd. - Pharmaceuticals & Healthcare - Deals and                                                                                  Reference Code: GDPH213854D
Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                  Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Cobra Biologics Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................. 4
       Cobra Biologics Ltd., Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 .................................................................. 5
       Cobra Biologics Ltd., Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .............................................................. 6
       Cobra Biologics Ltd., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ................................................... 7
       Cobra Biologics Ltd., Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ............................................................... 8
       Cobra Biologics Ltd., Pharmaceuticals & Healthcare, Deal Details .................................................................................................... 9
          Partnerships.................................................................................................................................................................................... 9
             Cobra Biologics Enters Into Co-Development Agreement With Algeta ....................................................................................... 9
             Cobra Biologics Enters Into Co-Development Agreement With Kahr Medical For KAHR-101 And KAHR-102 ......................... 10
          Acquisition .................................................................................................................................................................................... 12
             Cobra Biologics Acquires Unitech Pharma................................................................................................................................ 12
             Cobra Biologics Holding Acquires RecipharmCobra Biologics From Recipharm ...................................................................... 13
       Cobra Biologics Ltd. - Key Competitors ............................................................................................................................................ 14
       Key Employees ................................................................................................................................................................................ 15
       Locations And Subsidiaries .............................................................................................................................................................. 16
          Head Office ................................................................................................................................................................................... 16
          Other Locations & Subsidiaries ..................................................................................................................................................... 16
       Recent Developments ...................................................................................................................................................................... 17
          Government and Public Interest ................................................................................................................................................... 17
             Mar 26, 2013: Cobra Biologics And University Of Birmingham Receive Innovation Grant From Biotechnology And Biological
             Sciences Research Council ...................................................................................................................................................... 17
          Product News ...................................................................................................
								
To top